HPV Vaccines
HPV Vaccines
PAS 2017: Vaccine Reduces Human Papillomavirus Prevalence Among Young Women
- Details
- Category: HPV Vaccines
- Published on Tuesday, 16 May 2017 00:00
- Written by Liz Highleyman
The prevalence of human papillomavirus (HPV) types included in the most widely used vaccine has decreased among adolescent and young women in the U.S., with "herd immunity" extending to those who were not vaccinated themselves, according to study results presented at the Pediatric Academic Societies Meeting last week in San Francisco.
Young Adolescents Need Only 2 Doses of Human Papillomavirus Vaccine, CDC Says
- Details
- Category: HPV Vaccines
- Published on Tuesday, 08 November 2016 00:00
- Written by Liz Highleyman
Adolescents age 11-14 years can receive 2 doses of the human papillomavirus (HPV) vaccine to prevent cancers caused by HPV, rather than the 3 doses previously recommended, according to the U.S. Centers for Disease Control and Prevention (CDC). This change is supported by a systematic review presented at the recent IDWeek meeting in New Orleans, which found that 2 vaccine doses were non-inferior to 3 doses for this age group.
Single Dose of Human Papillomavirus Vaccine May Prevent Most Cervical Cancer
- Details
- Category: HPV Vaccines
- Published on Wednesday, 17 June 2015 00:00
- Written by Liz Highleyman
Just 1 dose of the Cervarix human papillomavirus (HPV) vaccine was able to protect 85% of young women against cancer-causing HPV types 16 and 18, suggesting that it could prevent a majority of cervical cancer cases, including in settings were administration of the full 3-dose series is difficult, according to an analysis of data from 2 large trials published in the June 9 edition of Lancet Oncology.
Gardasil HPV Vaccine Reduces Occurrence of Genital Warts and Cervical Dysplasia
- Details
- Category: Human Papillomavirus (HPV)
- Published on Thursday, 30 June 2016 00:00
- Written by Liz Highleyman
Countries that widely use a quadrivalent human papillomavirus (HPV) vaccine have seen up to a 90% reduction in HPV infections and decreases in the incidence of genital warts and cervical cell abnormalities that can lead to cancer, according to an analysis of nearly 60 studies from 9 countries presented at the European Research Organization on Genital Infection and Neoplasia and published in the May 26 edition of Clinical Infectious Diseases.
12. New Human Papillomavirus Vaccine Protects Against 9 Strains
- Details
- Category: Human Papillomavirus (HPV)
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
In December the U.S. Food and Drug Administration (FDA) approved a new "9-valent" human papillomavirus (HPV) vaccine from Merck that protects against more cancer-causing strains. The new Gardasil 9 vaccine is expected to prevent about 90% of cervical, anal, and genital cancers. The vaccine is approved for young women ages 9-26 and young men ages 9-15.
Web Design and Development by